Key Players are Cipla, GSK, Koninklijke Philips, and Lupin
The global asthma spacers market has increased at a significant CAGR during the years 2016-2020, and projections are made that the market would rise in the next four years i.e. 2021-2025.
The asthma spacers market is expected to increase due to surging prevalence of asthma, increasing obesity and overweight rate, upsurge in cigarette consumption, rising health care expenditure, rapid urbanization, increase in the ease of administration, etc. Yet the market faces some challenges such as availability of substitutes, lack of awareness, etc.
Scope of the Report
The report provides an in depth analysis of the global asthma spacers market by value, by spacer type, by distribution channel, by region, etc. The report provides a detailed regional analysis of the asthma spacers market, including the following regions: North America (the US, Canada & rest of North America); Europe (Germany, UK, France, Spain, Italy & Rest of Europe); Asia-Pacific (China, Japan, India, South Korea & Rest of Asia-Pacific); and Rest of the World. The report also provides a detailed analysis of the COVID-19 impact on the asthma spacers market.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global asthma spacers market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global asthma spacers market is fragmented with many major market players operating worldwide. Many local and regional spacer manufacturers are offering asthma spacers based on specific spacer type. The key players of the asthma spacers market are Cipla Limited, GlaxoSmithKline plc (GSK), Koninklijke Philips N.V., and Lupin Limited, which are also profiled with their financial information and respective business strategies.
Country Coverage
- North America
- Europe
- Asia-Pacific
- Rest of the World
Company Coverage
- Cipla Limited
- GlaxoSmithKline plc (GSK)
- Koninklijke Philips N.V.
- Lupin Limited
Table of Contents
1. Executive Summary
2. Introduction
2.1 Asthma: An Overview
2.1.1 Types of Asthma
2.1.2 Devices Used to Treat Asthma
2.2 Asthma Spacer: An Overview
2.2.1 Benefits of Using an Asthma Spacer
2.2.2 History of Inhalers and Asthma Spacers
2.2.3 Value Chain of Asthma Spacers
2.3 Asthma Spacer Segmentation: An Overview
2.3.1 Asthma Spacers Segmentation by Spacer Type
2.3.2 Asthma Spacers Segmentation by Distribution Channel
3. Global Market Analysis
3.1 Global Asthma Spacers Market: An Analysis
3.1.1 Global Asthma Spacers Market by Value
3.1.2 Global Asthma Spacers Market by Spacer Type (Volumatic, Aerochamber, Inspirease, Optichamber and Others)
3.1.3 Global Asthma Spacers Market by Distribution Channel (Hospital Pharmacy, Online Pharmacy and Retail Pharmacy)
3.1.4 Global Asthma Spacers Market by Region (North America, Europe, Asia Pacific and Rest of the World)
3.2 Global Asthma Spacers Market: Spacer Type Analysis
3.2.1 Global Volumatic Asthma Spacers Market by Value
3.2.2 Global Aerochamber Asthma Spacers Market by Value
3.2.3 Global Inspirease Asthma Spacers Market by Value
3.2.4 Global Optichamber Asthma Spacers Market by Value
3.2.5 Global Others Asthma Spacers Market by Value
3.3 Global Asthma Spacers Market: Distribution Channel Analysis
3.3.1 Global Hospital Pharmacy Asthma Spacers Market by Value
3.3.2 Global Online Pharmacy Asthma Spacers Market by Value
3.3.3 Global Retail Pharmacy Asthma Spacers Market by Value
4. Regional Market Analysis
4.1 North America Asthma Spacers Market: An Analysis
4.1.1 North America Asthma Spacers Market by Value
4.1.2 North America Asthma Spacers Market by Spacer Type (Volumatic, Aerochamber, Inspirease, Optichamber and Others)
4.1.3 North America Asthma Spacers Market Type by Value
4.1.4 North America Asthma Spacers Market by Distribution Channel (Hospital Pharmacy, Online Pharmacy and Retail Pharmacy)
4.1.5 North America Asthma Spacers Market Distribution Channel by Value
4.1.6 North America Asthma Spacers Market by Region (The US, Canada and Rest of North America)
4.1.7 North America Asthma Spacers Market Regions by Value
4.2 Europe Asthma Spacers Market: An Analysis
4.2.1 Europe Asthma Spacers Market by Value
4.2.2 Europe Asthma Spacers Market by Spacer Type (Volumatic, Aerochamber, Inspirease, Optichamber and Others)
4.2.3 Europe Asthma Spacers Market Type by Value
4.2.4 Europe Asthma Spacers Market by Distribution Channel (Hospital Pharmacy, Online Pharmacy and Retail Pharmacy)
4.2.5 Europe Asthma Spacers Market Distribution Channel by Value
4.2.6 Europe Asthma Spacers Market by Region
4.2.7 Europe Asthma Spacers Market Regions by Value (UK, Germany, Italy, France, Spain and rest of Europe)
4.3 Asia Pacific Asthma Spacers Market: An Analysis
4.3.1 Asia Pacific Asthma Spacers Market by Value
4.3.2 Asia Pacific Asthma Spacers Market by Spacer Type (Volumatic, Aerochamber, Inspirease, Optichamber and Others)
4.3.3 Asia Pacific Asthma Spacers Market Type by Value
4.3.4 Asia Pacific Asthma Spacers Market by Distribution Channel (Hospital Pharmacy, Online Pharmacy and Retail Pharmacy)
4.3.5 Asia Pacific Asthma Spacers Market Distribution Channel by Value
4.3.6 Asia Pacific Asthma Spacers Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
4.3.7 Asia Pacific Asthma Spacers Market Regions by Value
4.4 Rest of the World Asthma Spacers Market: An Analysis
4.4.1 Rest of the World Asthma Spacers Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Asthma Spacer Market
5.1.2 Cumulative Number of COVID-19 Confirmed Cases
5.1.3 Shortage of Oxygen Supply and Devices
6. Market Dynamics
6.1 Growth Driver
6.1.1 Surging Prevalence of Asthma
6.1.2 Increasing Obesity and Overweight Rate
6.1.3 Upsurge in Cigarette Consumption
6.1.4 Rising Health Care Expenditure
6.1.5 Rapid Urbanization
6.1.6 Increase in the Ease of Administration
6.2 Challenges
6.2.1 Availability of Substitutes
6.2.2 Lack of Awareness
6.2.3 Cumbersome Regulations
6.3 Market Trends
6.3.1 Rising e-Commerce Sales of Health-related Products
6.3.2 Increasing Pollution
6.3.3 Growing Initiatives Towards Respiratory Diseases
6.3.4 Growing Strategic Alliances
7. Competitive Landscape
7.1 Global Asthma Spacers Market Players: A Financial Comparison
7.2 Global Asthma Spacer Market Players by Main Focus Areas
7.3 Global Asthma Spacer Market Players by Spacers Product
8. Company Profiles
8.1 Cipla Limited
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 GlaxoSmithKline plc (GSK)
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Koninklijke Philips N.V.
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Lupin Limited
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy
List of Figures
Figure 1: Types of Asthma
Figure 2: Devices Used to Treat Asthma
Figure 3: Benefits of Using an Asthma Spacer
Figure 4: History of Inhalers and Asthma Spacers
Figure 5: Value Chain of Asthma Spacers
Figure 6: Asthma Spacers Segmentation by Spacer Type
Figure 7: Asthma Spacers Segmentation by Distribution Channel
Figure 8: Global Asthma Spacers Market by Value; 2016-2020 (US$ Billion)
Figure 9: Global Asthma Spacers Market by Value; 2021-2025 (US$ Billion)
Figure 10: Global Asthma Spacers Market by Spacer Type; 2020 (Percentage, %)
Figure 11: Global Asthma Spacers Market by Distribution Channel; 2020 (Percentage, %)
Figure 12: Global Asthma Spacers Market by Region; 2020 (Percentage, %)
Figure 13: Global Volumatic Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 14: Global Volumatic Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 15: Global Aerochamber Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 16: Global Aerochamber Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 17: Global Inspirease Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 18: Global Inspirease Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 19: Global Optichamber Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 20: Global Optichamber Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 21: Global Others Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 22: Global Others Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 23: Global Hospital Pharmacy Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 24: Global Hospital Pharmacy Asthma Spacers Market by Value 2021-2025; (US$ Million)
Figure 25: Global Online Pharmacy Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 26: Global Online Pharmacy Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 27: Global Retail Pharmacy Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 28: Global Retail Pharmacy Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 29: North America Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 30: North America Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 31: North America Asthma Spacers Market by Spacer Type; 2020 (Percentage, %)
Figure 32: North America Asthma Spacers Market Type by Value; 2016-2025 (US$ Million)
Figure 33: North America Asthma Spacers Market by Distribution Channel; 2020 (Percentage, %)
Figure 34: North America Asthma Spacers Market Distribution Channel by Value; 2016-2025 (US$ Million)
Figure 35: North America Asthma Spacers Market by Region; 2020 (Percentage, %)
Figure 36: North America Asthma Spacers Market Regions by Value; 2016-2025 (US$ Million)
Figure 37: Europe Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 38: Europe Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 39: Europe Asthma Spacers Market by Spacer Type; 2020 (Percentage, %)
Figure 40: Europe Asthma Spacers Market Type by Value; 2016-2025 (US$ Million)
Figure 41: Europe Asthma Spacers Market by Distribution Channel; 2020 (Percentage, %)
Figure 42: Europe Asthma Spacers Market Distribution Channel by Value; 2016-2025 (US$ Million)
Figure 43: Europe Asthma Spacers Market by Region; 2020 (Percentage, %)
Figure 44: Europe Asthma Spacers Market Regions by Value; 2016-2025 (US$ Million)
Figure 45: Asia Pacific Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 46: Asia Pacific Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 47: Asia-Pacific Asthma Spacers Market by Spacer Type; 2020 (Percentage, %)
Figure 48: Asia Pacific Asthma Spacers Market Type by Value; 2016-2025 (US$ Million)
Figure 49: Asia Pacific Asthma Spacers Market by Distribution Channel; 2020 (Percentage, %)
Figure 50: Asia Pacific Asthma Spacers Market Distribution Channel by Value; 2016-2025 (US$ Million)
Figure 51: Asia Pacific Asthma Spacers Market by Region; 2020 (Percentage, %)
Figure 52: Asia Pacific Asthma Spacers Market Regions by Value; 2016-2025 (US$ Million)
Figure 53: Rest of the World Asthma Spacers Market by Value; 2016-2020 (US$ Million)
Figure 54: Rest of the World Asthma Spacers Market by Value; 2021-2025 (US$ Million)
Figure 55: Cumulative Number of COVID-19 Confirmed Cases; 2020-2021; (Million)
Figure 56: The US and Europe Shortage of Oxygen Supply and Devices; 2020 (Percentage, %)
Figure 57: Global Asthmatic Population; 2015-2019 (Million)
Figure 58: Global Prevalence of Overweight and Obesity by Region; 2019-2020 (Percentage, %)
Figure 59: Global Cigarette Consumption; 2015-2020 (Trillion)
Figure 60: Global Health Spend by Region; 2015-2021 (US$ Trillion)
Figure 61: Global Urbanization Rates by Region; 2010-2040 (Percentage, %)
Figure 62: The US Health, Personal Care & Beauty Retail E-Commerce Sales; 2018-2022 (US$ Million)
Figure 63: The US Energy Related Carbon Dioxide Emissions by Sector; 2000-2030 (Billion Metric Ton)
Figure 64: Cipla Limited Revenue; 2016-2020 (US$ Billion)
Figure 65: Cipla Limited Revenue by Region; 2020 (Percentage, %)
Figure 66: Cipla Limited Revenue by Segments; 2020 (Percentage, %)
Figure 67: GlaxoSmithKline plc (GSK) Turnover; 2016-2020 (US$ Billion)
Figure 68: GlaxoSmithKline plc (GSK) Turnover by Segments; 2020 (Percentage, %)
Figure 69: GlaxoSmithKline plc (GSK) Turnover by Region; 2020 (Percentage, %)
Figure 70: Koninklijke Philips N.V. Sales; 2016-2020 (US$ Billion)
Figure 71: Koninklijke Philips N.V. Sales by segments; 2020 (Percentage, %)
Figure 72: Koninklijke Philips N.V. Sales by Region; 2020 (Percentage, %)
Figure 73: Lupin Limited Sales; 2016-2020 (US$ Billion)
Figure 74: Lupin Limited Sales by Segments; 2020 (Percentage, %)
Figure 75: Lupin Limited Sales by Region; 2020 (Percentage, %)
List of Tables
Table 1: Global Asthma Spacers Market Players: A Financial Comparison; 2020
Table 2: Global Asthma Spacer Market Plyers by Main Focus Areas
Table 3: Global Asthma Spacer Market Players by Spacers Product
Samples
LOADING...
Executive Summary
Asthma spacer is a medical device, usually like a plastic tube, that is used as an attachment with the inhalers. It reduces the risk associated with the heavy dose of preventer medicine. The medicine usually gets deposited on the tongue or at the back of the throat, when taken contemporarily. Asthma spacers distribute the medicine evenly and makes it reach directly to the lungs.
The major benefits provided by asthma spacer include more medication reached to the lungs, making the treatment more effective, making it easier to take aerosolized medication, less medication is deposited in the mouth and throat, no need of coordinating puff press and breathing in at the same time, and improvement in drug delivery to lungs. The value chain of asthma spacers starts with raw material suppliers, then manufacturers, followed by distribution channels and finally reaches the end users.
The asthma spacers market can be segmented on the basis of spacer type (Volumatic, Aerochamber, Inspirease, Optichamber, and Others); and distribution channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy).
Companies Mentioned
- Cipla Limited
- GlaxoSmithKline plc (GSK)
- Koninklijke Philips N.V.
- Lupin Limited
